BackCytomX Therapeutics Overview

CytomX Therapeutics Operating Income

Operating Income for CTMX.

Quarterly Operating Income

$-19672000.00
↓ 186.96% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-64658000.00
↓ 279.81% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin